Breaking the mold: asciminib as a standard of care of the therapeutic armamentarium of chronic myeloid leukemia in the upfront setting.

Yılmaz R., Eşkazan A. E.

Future oncology (London, England), vol.19, pp.545-547, 2023 (SCI-Expanded, Scopus)

  • Publication Type: Article / Editorial Material
  • Volume: 19
  • Publication Date: 2023
  • Doi Number: 10.2217/fon-2023-0095
  • Journal Name: Future oncology (London, England)
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, EMBASE, MEDLINE
  • Page Numbers: pp.545-547
  • Istanbul University-Cerrahpasa Affiliated: Yes